Meshaal Alanzi

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Hodgkin Lymphoma

Resistance Training

Diffuse Large B Cell Lymphoma

Top Venues

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Meshaal Alanzi, Mohammad Abu-Tineh, Lajos Szabados, M Z Sharaf Eldean, Sali Alatasi, Ruba Y Taha, Sarah A Elkourashy
Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report. OncoTargets and therapy 16 (2023)
Meshaal Alanzi, Mohammad Abu-Tineh, Lajos Szabados, M Z Sharaf Eldean, Sali Alatasi, Ruba Y Taha, Sarah A Elkourashy
Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report. OncoTargets and therapy 16 (2023)